*If You Own DBVT, HAE, CTRM Then Click Here to Join Our Community Of Traders
The Market Signal was created as a platform to help investors, if you own (NASDAQ:DBVT), (NYSE:HAE) or (NASDAQ:CTRM) and want to join the fastest growing community of investors on the web then sign up to the link below. Members get free access to the best investment tools in the world. Start trading like a pro today. This is a limited time offer so click the link below NOW.
https://themarketsignal.com/Free-Report/NOW
(Click link above or copy, paste and hit enter in your browser for your report)
DBV Technologies Reports H1-20
https://themarketsignal.com/Free-Report/DBVT
(Click link above or copy, paste and hit enter in your browser for your report)
DBV TECHNOLOGIES ADR (NASDAQ:DBVT) is reflecting bullish signals with a RSI of 19.89. The clinical-stage biopharmaceutical company reported financial figures for the H1-20. DBVT reported EUR225.9 million cash and cash equivalents at the end of H1-20. This compares with EUR172.0 million in the previous half year ending December 31, 2019, reflecting EUR53.8 million increase.
The company used EUR79.4 million cash in operating activities, while EUR1.3 million was generated from investment activities. DBVT reported EUR7.6 million operating income in H1-20 as against EUR7.1 million in H1-19. This income generation is attributed to income recognized from Research Tax Credit of the Company.
During the first half of this year, the company reported EUR86.5 million net loss, as against EUR79.8 million in H1-19.
Haemonetics Reported First Quarter Fiscal 2021 Financial Results
https://themarketsignal.com/Free-Report/HAE
(Click link above or copy, paste and hit enter in your browser for your report)
RSI of Haemonetics Corporation (NYSE:HAE) is 19.96 and the stock looks bullish. The company reported financial results for first quarter of fiscal 2021. In Q1-21 the company reported $196 million revenue, decreasing 18% from a year before. There has been a 16% organic revenue decline. The earnings per diluted share in Q1-21 came in at $0.21. During the first quarter of fiscal 2021, the adjusted earnings per diluted share came in at $0.46.
The company generated $12 million Cash flow from operating activities during the first quarter of fiscal 2021. Free cash flow before restructuring & turnaround during the reported quarter came in at $11 million.
The company also reported 46.0% gross margin in Q1-21, down 260 basis points in comparison with Q1-20.
Castor Maritime Procures Panamax Dry Bulk Carrier For $12.75 Million
https://themarketsignal.com/Free-Report/CTRM
(Click link above or copy, paste and hit enter in your browser for your report)
Castor Maritime Inc. (NASDAQ:CTRM) appears to be a bullish stock with a RSI of 24.40. The company, on July 30 signed an agreement for procuring second-hand bulk carrier for a price of $12.75 million. This is the panamax dry bulk carrier, 2010 model, built in Japan. This bulk carrier will be procured by Castor by Q3-2020 end or by the beginning of Q4-2020.
Earlier, the company had raised funds, stating that net proceeds generated from share sale will be used for vessel acquisition. Castor Maritime is moving ahead in line with its renewal and expansion plan that was pre-decided in 2019.
Please email or contact us for any edits or errors relating to this stock market news.
If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market and other Stock Market news.
We will get back to you within 24 hours.
The post Healthy RSI Indicates Bullish Signals For US Stocks: $DBVT $HAE $CTRM appeared first on The Market Signals.
COMTEX_368917291/2700/2020-08-05T09:18:42
Is there a problem with this press release? Contact the source provider Comtex at editorialpr@comtex.com.
